NewsRx

Search our medical news database

Diabetes

New research from Japan, the United Kingdom and the People's Republic of China in the area of diabetes detailed

Published in Obesity and Diabetes Week, October 30th, 2006

Investigators in Japan, the United Kingdom and the People's Republic of China have published new diabetes data.

Study 1: In nonobese type 2 diabetic patients thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 are differently correlated with metabolic factors.

According to recent research from Japan, "We investigated the plasma levels of thrombin-activatable fibrinolysis inhibitor (TAFI), plasminogen activator inhibitor-1 (PAI-1) and their relation with clinical and metabolic parameters in nonobese type 2 diabetic patients. The plasma levels of TAFI and PAI-1 were evaluated in 47 nonobese type 2 diabetic patients and 31...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook